200 related articles for article (PubMed ID: 26692195)
41. Cardiac granulocytic sarcoma (chloroma): in vivo diagnosis with transesophageal echocardiography.
Marcos-Alberca P; Ibáñez B; Rey M; Román A; Rábago R; Orejas M; Tomás JF; Farré J
J Am Soc Echocardiogr; 2004 Sep; 17(9):1000-2. PubMed ID: 15337968
[TBL] [Abstract][Full Text] [Related]
42. 18 F-FDG PET/CT Findings of Myeloid Sarcoma Involving the Left Ventricle and Kidney in a Pediatric Patient.
Zhang M; Yang X; Si Y; Kan Y; Yang J
Clin Nucl Med; 2023 Jan; 48(1):103-105. PubMed ID: 36179330
[TBL] [Abstract][Full Text] [Related]
43. Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Korn RL; Yost AM; May CC; Kovalsky ER; Orth KM; Layton TA; Drumm D
AJR Am J Roentgenol; 2006 Jul; 187(1):81-5. PubMed ID: 16794159
[TBL] [Abstract][Full Text] [Related]
44. [Diagnostic and therapeutic impact of 18F-FDG-PET/CT in patients with suspected breast cancer recurrence].
Palomar Muñoz A; García Vicente AM; Talavera Rubio MP; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; León Martín A; Cordero García JM; Soriano Castrejón A
Rev Esp Med Nucl; 2010; 29(3):100-8. PubMed ID: 20392542
[TBL] [Abstract][Full Text] [Related]
45. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
[TBL] [Abstract][Full Text] [Related]
46. Butterfly lesion of the corpus callosum: an unusual case of extramedullary myeloid sarcoma (granulocytic sarcoma).
Kei PL; Kok TY; Linn YC; Padhy AK
Clin Nucl Med; 2011 May; 36(5):365-6. PubMed ID: 21467855
[No Abstract] [Full Text] [Related]
47. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
[No Abstract] [Full Text] [Related]
48. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
49. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Avery R; Kuo PH
Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
[TBL] [Abstract][Full Text] [Related]
50. Activity of decitabine in pericardial myeloid sarcoma.
Evers D; Bär BMAM; Gotthardt M; van der Velden WJFM
Int J Hematol; 2018 Aug; 108(2):121-122. PubMed ID: 29779081
[No Abstract] [Full Text] [Related]
51. Role of 18 FDG PET/CT in Breast Cancer.
Fatima N; Maseeh UZ
J Coll Physicians Surg Pak; 2018 Mar; 28(3):177-179. PubMed ID: 29544570
[No Abstract] [Full Text] [Related]
52. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
53. FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Dong A; Gao M; Wang Y; Gao L; Zuo C
Clin Nucl Med; 2016 Sep; 41(9):e414-6. PubMed ID: 26909714
[TBL] [Abstract][Full Text] [Related]
54. A rare case of clear cell carcinoma of the breast evaluated by (18)F-FDG PET/CT.
Treglia G; Perriard U; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):264-5. PubMed ID: 25573809
[No Abstract] [Full Text] [Related]
55. Breast angiosarcoma: FDG PET findings.
Zeng W; Styblo TM; Li S; Sepulveda JN; Schuster DM
Clin Nucl Med; 2009 Jul; 34(7):443-5. PubMed ID: 19542952
[No Abstract] [Full Text] [Related]
56. Isolated extramedullary relapse of acute myelogenous leukemia as a uterine granulocytic sarcoma in an allogeneic hematopoietic stem cell transplantation recipient.
Maeng H; Cheong JW; Lee ST; Yang WI; Hahn JS; Ko YW; Min YH
Yonsei Med J; 2004 Apr; 45(2):330-3. PubMed ID: 15119007
[TBL] [Abstract][Full Text] [Related]
57. ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.
Groheux D; Cochet A; Humbert O; Alberini JL; Hindié E; Mankoff D
J Nucl Med; 2016 Feb; 57 Suppl 1():17S-26S. PubMed ID: 26834096
[TBL] [Abstract][Full Text] [Related]
58. Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
Bitencourt AG; Lima EN; Chojniak R; Marques EF; Souza JA; Andrade WP; Guimarães MD
Eur J Radiol; 2014 Aug; 83(8):1381-6. PubMed ID: 24931922
[TBL] [Abstract][Full Text] [Related]
59. Positron emission tomography/magnetic resonance imaging of the breast.
Sher A; Vercher-Conejero JL; Muzic RF; Avril N; Plecha D
Semin Roentgenol; 2014 Oct; 49(4):304-12. PubMed ID: 25498227
[No Abstract] [Full Text] [Related]
60. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
